SKI Market

A+| A| A-|

Indian Indices

Sensex

77,616.40 47.01
( 0.06%)

Global Indices

Nasdaq

52,658.24 149.83
(0.29%)

Dow Jones

7,594.79 30.15
(0.40%)

Hang Seng

67,217.35 -1,340.38
(-1.96%)

Nikkei 225

10,498.02 25.57
(0.24%)

Forex

USD-INR

95.45 -0.01
(-0.01%)

EUR-INR

109.10 0.17
(0.15%)

GBP-INR

127.94 0.35
(0.28%)

JPY-INR

0.59 0.00
(0.03%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sanofi India Ltd

Industry : Pharmaceuticals - Multinational

BSE Code

ISIN Demat

Book Value()

500674

INE058A01010

325.3278333

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SANOFI

23.89

7854.61

EPS(TTM)

Face Value()

Div & Yield %

142.76

3.6

Back

FDC receives USFDA approval for Cefixime for Oral Suspension

May 18,2026

FDC has granted ANDA approval by United States Food and Drug Administration (U.S.FDA), for Cefixime for Oral Suspension USP, 100 mg / 5 mL and 200 mg/ 5 mL.

77,616.40 47.01 ( 0.06%)

52,658.24 149.83 (0.29%)

7,594.79 30.15 (0.40%)

67,217.35 -1,340.38 (-1.96%)

10,498.02 25.57 (0.24%)

95.45 -0.01 (-0.01%)

109.10 0.17 (0.15%)

127.94 0.35 (0.28%)

0.59 0.00 (0.03%)